| Website | aggredyne.com |
| Category | BioTech |
| Phone | (713) 636-5996 |
| Employees |
| TOTAL | $3M |
| FUNDING TOTAL | $3M |
| Series A, 4/12 | $3M |
Aggredyne, Inc. (www.aggredyne.com), is a biomedical company founded in 2011 by Edward R. Teitel, MD, JD, and Robert C. Hux, CPA, to commercialize the AggreGuideTM platelet function analyzer. The AggreGuide system is an in-vitro diagnostic test that measures how sticky a patient’s platelets are and how well the patient is responding to antiplatelet medications such as aspirin or Plavix® (clopidogrel), Effient® (prasugrel) and Brillinta® (ticagrelor).
